IOL Chemicals and Pharmaceuticals Limited
13 Aug 2026
-
Hi sir. Maulik here from 360 ONE Capital. Thank you for the opportunity and congratulations on a good set of numbers. Sir, a few questions from my side. So, we've seen growth -- strong top line growth across all products. So just wanted some qualitative idea from your side, why was this growth muted in the last few quarters?
Read in transcript -
Okay. Okay, sir. And any guidance, sir, on FY '28? Will we be able to grow in similar run rate of 15%, 20% in terms of top line and also on EBITDA margin, sir? Any guidance on that?
Read in transcript -
Okay. Okay. Okay. EBITDA margin, you are slightly upgrading in terms of volume -- better volume and pricing scenario.
Read in transcript